Purpose. The NOD mouse, as well as the newly constructed C57BL/6.NOD-Aec1Aec2 mouse, have been shown to exhibit numerous disease parameters that parallel Sjogren’s syndrome (SjS) in humans, including loss of stimulated fluid secretion concomitant with the appearance of leukocytic infiltrates in the lacrimal and salivary glands. In the present study, we have catalogued the temporal changes in tear proteins with the onset of dry eye disease in these two mouse strains. Methods. Tears, collected from CD-1, NOD.B10-H2b and C57BL/6.NOD-Aec1Aec2 mice at 3, 8, 14, and 20 weeks of age, were labeled with either Cy-3 (green) or Cy-5 (red) dye. Labeled tear proteins were separated individually on pH3-10 NL18 cm IPG strips, then electrophoresed through 8-16% Tris-HCl SDS-polyacrylamide gels. Each gel was scanned for visualization using ImageQuant software. Each gel was compared by ImageMaster 2-D Elite software to identify unique protein difference. Each protein spot was sequenced using MOLDI-TOF. Results. NOD.B10-H2b and C57BL/6.NODAec1Aec2 mice exhibited marked losses in their tear protein concentrations compared to CD-1 mice. To date, nearly 50 protein spots have been compared between the autoimmune and nonautoimmune mice. Some 10 tear proteins remained unchanged through 20 weeks of age (e.g., lacrimal androgen binding protein); however, the majority of tear proteins showed some increased levels in the autoimmune mice (e.g., DNAseI orglobulin IV precursor), while >12 spots were lost in conjunction with the onset of dry eye disease. Conclusions. Onset of dry eye disease in mice exhibiting SjS-like disease is associated with loss of tear volume, decreased tear protein concentrations, loss in expression of several tear proteins, plus appearance of altered proteins. Commercial Relationship(s): ABP is a scientific consultant for and stockholder in Ixion Biotechnology, Inc.; Support: NIH grants DE13769, DE014344 & DE015152